Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg)Jan 1, 2016·Chi Tung Choy,Chi Hang Wong,Herbert Ho Fung Loong· 0 min read CiteLast updated on Jan 1, 2016 ← Preclinical study on the efficacy of Panobinostat in hepatocellular carcinoma Jan 1, 2017ATPS-51ESTABLISHING THE ROLE OF ARGININE DEPRIVATION WITH THE RECOMBINANT HUMAN ARGINASE PEG-BCT-100 IN THE TREATMENT OF ADULT GLIOMAS Jan 1, 2015 →